{"log_id": 668963573443992694, "direction": 0, "words_result_num": 34, "words_result": [{"probability": {"variance": 0.002209, "average": 0.950622, "min": 0.903625}, "location": {"width": 37, "top": 139, "height": 27, "left": 1114}, "words": "总丿"}, {"probability": {"variance": 0, "average": 0.997051, "min": 0.997051}, "location": {"width": 30, "top": 175, "height": 30, "left": 1111}, "words": "件"}, {"probability": {"variance": 1.5e-05, "average": 0.997586, "min": 0.985608}, "location": {"width": 223, "top": 206, "height": 28, "left": 260}, "words": "鞘内注射途径给药的使用"}, {"probability": {"variance": 4e-06, "average": 0.997699, "min": 0.994219}, "location": {"width": 223, "top": 247, "height": 25, "left": 260}, "words": "硬脑膜外途径给药的使用"}, {"probability": {"variance": 0.000624, "average": 0.989317, "min": 0.878156}, "location": {"width": 698, "top": 285, "height": 29, "left": 225}, "words": "禁止对正在接受皮质类固醇类免疫抑制剂量治疗的患者使用活疫苗或减毒活疫苗"}, {"probability": {"variance": 1.9e-05, "average": 0.997406, "min": 0.988651}, "location": {"width": 102, "top": 368, "height": 23, "left": 222}, "words": "相对禁忌症"}, {"probability": {"variance": 1e-06, "average": 0.999028, "min": 0.997363}, "location": {"width": 124, "top": 407, "height": 24, "left": 219}, "words": "特殊危险人群"}, {"probability": {"variance": 0.000886, "average": 0.994296, "min": 0.813366}, "location": {"width": 753, "top": 443, "height": 27, "left": 220}, "words": "对属于下列特殊危险人群的患者应采取严密的医疗监护并应尽可能缩短疗程(同时参阅"}, {"probability": {"variance": 0.01422, "average": 0.96312, "min": 0.423223}, "location": {"width": 776, "top": 482, "height": 29, "left": 194}, "words": "【注意事项】和【不良反应):儿童;糖尿病患者;高血压患者;有精神病史者;有明显症"}, {"probability": {"variance": 2.6e-05, "average": 0.997989, "min": 0.975596}, "location": {"width": 794, "top": 521, "height": 28, "left": 180}, "words": "状的某些感染性疾病,如结核病;或有明显症状的某些病毒性疾病,如波及眼部的疱疹及带"}, {"probability": {"variance": 1.4e-05, "average": 0.997257, "min": 0.991906}, "location": {"width": 61, "top": 565, "height": 23, "left": 180}, "words": "状疱疹"}, {"probability": {"variance": 0.000321, "average": 0.994695, "min": 0.90109}, "location": {"width": 579, "top": 600, "height": 30, "left": 222}, "words": "为避免相容性和稳定性问题,应尽可能将本品与其它药物分开给药"}, {"probability": {"variance": 0.003855, "average": 0.9687, "min": 0.844521}, "location": {"width": 106, "top": 683, "height": 23, "left": 194}, "words": "注意事项〗"}, {"probability": {"variance": 0.007664, "average": 0.976014, "min": 0.648451}, "location": {"width": 291, "top": 719, "height": 28, "left": 182}, "words": "免疫抑制剂作用/感染易感性增高"}, {"probability": {"variance": 8e-06, "average": 0.998945, "min": 0.985561}, "location": {"width": 751, "top": 757, "height": 29, "left": 221}, "words": "皮质类固醇可能会增加感染的易感性,可能掩盖感染的一些症状,而且在皮质类固醇的"}, {"probability": {"variance": 1.4e-05, "average": 0.998052, "min": 0.979567}, "location": {"width": 779, "top": 795, "height": 32, "left": 183}, "words": "使用过程中可能会出现新的感染。使用皮质类固醇可能会减弱抵抗力而无法使感染局限化"}, {"probability": {"variance": 0.004543, "average": 0.987889, "min": 0.56719}, "location": {"width": 790, "top": 835, "height": 29, "left": 183}, "words": "在人体任何部位出现的,由包括病毒、细菌、真菌、原生动物或蠕虫生物体的任何一种病原"}, {"probability": {"variance": 5.9e-05, "average": 0.996012, "min": 0.95721}, "location": {"width": 790, "top": 874, "height": 30, "left": 183}, "words": "体引发的感染,可能与皮质类固醇的单独使用或者它与其它影响细胞或体液免疫、或者中性"}, {"probability": {"variance": 7e-06, "average": 0.998722, "min": 0.98531}, "location": {"width": 778, "top": 914, "height": 27, "left": 185}, "words": "粒细胞功能的免疫抑制剂的联合使用有关系。这些感染可能是轻度的,但也可以是严重的"}, {"probability": {"variance": 2.3e-05, "average": 0.9978, "min": 0.971913}, "location": {"width": 700, "top": 952, "height": 28, "left": 183}, "words": "有时甚至是致命的。随着皮质类固醇剂量的增加,感染并发症的发生率也会增加"}, {"probability": {"variance": 6.4e-05, "average": 0.996599, "min": 0.96106}, "location": {"width": 745, "top": 990, "height": 30, "left": 224}, "words": "正在服用抑制免疫系统药物的人比健康个体更容易患感染。例如,水痘和麻疹,对正在"}, {"probability": {"variance": 1.6e-05, "average": 0.99784, "min": 0.978339}, "location": {"width": 640, "top": 1030, "height": 27, "left": 184}, "words": "使用皮质类固醇的未免疫性儿童或成人来说,会更加严重,甚至是致命的"}, {"probability": {"variance": 0.00043, "average": 0.995339, "min": 0.869907}, "location": {"width": 748, "top": 1068, "height": 27, "left": 226}, "words": "同样地,对于已知患有或怀疑患有寄生虫感染的患者,如类圆线虫(蛲虫)感染,可能"}, {"probability": {"variance": 8e-06, "average": 0.998263, "min": 0.986708}, "location": {"width": 790, "top": 1105, "height": 32, "left": 184}, "words": "会导致类圆线虫高度感染及伴随广泛幼虫迁移的散播,常常伴有重度的小肠结肠炎和潜在致"}, {"probability": {"variance": 5e-06, "average": 0.99786, "min": 0.990158}, "location": {"width": 481, "top": 1145, "height": 31, "left": 184}, "words": "命的革兰阴性菌败血症,应非常谨慎地使用皮质类固醇"}, {"probability": {"variance": 0.005031, "average": 0.987635, "min": 0.556212}, "location": {"width": 748, "top": 1186, "height": 26, "left": 226}, "words": "禁止对正在接受皮质类固醇免疫抑制剂量治疗的患者使用活疫苗或减毒活疫苗。灭活疫"}, {"probability": {"variance": 1.3e-05, "average": 0.998463, "min": 0.978592}, "location": {"width": 790, "top": 1223, "height": 31, "left": 185}, "words": "苗可能可用于正在接受皮质类固醇免疫抑制剂量治疗的患者,但是,这种疫苗的反应可能会"}, {"probability": {"variance": 0.000399, "average": 0.992518, "min": 0.884754}, "location": {"width": 789, "top": 1261, "height": 32, "left": 185}, "words": "被减弱。这表明,正在接受非皮质类固醇免疫抑制剂量治疗的患者可接受适用的免疫接种程"}, {"probability": {"variance": 0, "average": 0.999912, "min": 0.999912}, "location": {"width": 26, "top": 1307, "height": 24, "left": 183}, "words": "序"}, {"probability": {"variance": 0.009842, "average": 0.966707, "min": 0.399899}, "location": {"width": 752, "top": 1339, "height": 32, "left": 225}, "words": "皮类固弊在活动性结核病中的使用应仅限于暴发性或扩散性结核病,皮质类固醇与适"}, {"probability": {"variance": 0.007236, "average": 0.976065, "min": 0.636093}, "location": {"width": 343, "top": 1375, "height": 33, "left": 186}, "words": "当的抗结核病疗法联合使用以控制病情"}, {"probability": {"variance": 0.008736, "average": 0.974238, "min": 0.553754}, "location": {"width": 753, "top": 1415, "height": 35, "left": 226}, "words": "如果皮质类固醇用于潜伏性结核病或结核菌素阳性反应的患者时,必须密切观察以防病"}, {"probability": {"variance": 0.003218, "average": 0.979766, "min": 0.693949}, "location": {"width": 603, "top": 1458, "height": 33, "left": 184}, "words": "情复发。这些果者在长期服用皮质类固醇期间,应接受化学预防治疗"}, {"probability": {"variance": 2e-06, "average": 0.998428, "min": 0.995462}, "location": {"width": 133, "top": 1546, "height": 23, "left": 516}, "words": "第9页/共20页"}], "language": 3}